Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Anesthetic management of a parturient with neuromyelitis optica.
Excitotoxic mechanisms of ischemic injury in myelinated white matter.
Biochemical and antiviral activity of MK-0518, a potent HIV integrase inhibitor
Association of a deficit of arousal with fatigue in multiple sclerosis: Effect of modafinil.
Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS
Longitudinal Penalized Functional Regression for Cognitive Outcomes on Neuronal Tract Measurements.
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress.
Navigating Life and Loss in Pediatric Multiple Sclerosis.
Cortico-juxtacortical involvement increases risk of epileptic seizures in multiple sclerosis.
Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease.
Multiple sclerosis reactivation postfingolimod cessation: Is it IRIS?
VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses.
Autologous T Cell Vaccine (TCV) for Multiple Sclerosis (TERMS)
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica.
Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study.
Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA.
Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Construct Validity, Responsiveness, and Interpretation.
Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients.
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
25-Hydroxycholecalciferol status in plasma is linearly correlated to daily summer pasture time in cattle at 56°N.
Iranian family caregivers' challenges and issues in caring of multiple sclerosis patients: A descriptive explorative qualitative study.
Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia.
The Impact of Social Media on Dissemination and Implementation of Clinical Practice Guidelines: A Longitudinal Observational Study.

Pages